frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
Published 11 years ago • 1.1K plays • Length 7:34Download video MP4
Download video MP3
Similar videos
-
3:57
agile trial: frontline axitinib versus sorafenib in metastatic renal cell carcinoma
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
7:58
utilizing frontline bevacizumab in metastatic renal cell carcinoma
-
1:25
dr. tannir on the combination of sunitinib and temsirolimus for metastatic renal cell carcinoma
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
5:09
comparz trial and alternate sunitinib dosing schedule in metastatic renal cell carcinoma
-
0:40
dr. robert dreicer on an alternate sunitinib schedule in metastatic renal cell carcinoma
-
4:06
sunitinib with or without surgery for metastatic renal cell carcinoma
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
7:04
sunitinib 4/2 vs 2/1 schedule for patients with mrcc
-
3:09
should sunitinib still be used in the treatment of metstatic kidney cancer?
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
8:57
introduction and review of the comparz trial in renal cell carcinoma
-
6:36
frontline clinical trials in renal cell carcinoma
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
4:28
metastatic renal cell carcinoma: lenvatinib phase ii data
-
4:38
determining progression in metastatic renal cell carcinoma
-
2:33
dr. hsieh discusses frontline treatment of kidney cancer with pazopanib and sunitinib
-
7:05
upfront immunotherapy for metastatic kidney cancer